Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 571-580 of 711 for Cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder

    Rochester, MN

  2. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR)

    Rochester, MN

  3. Perceived Financial Hardship in Patients with Multiple Myeloma and Their Caregivers

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC) (ACT-MBC)

    Eau Claire, WI, Mankato, MN, Rochester, MN, Albert Lea, MN

  5. Open Nipple Sparing Mastectomy (NSM)

    Rochester, MN

  6. A Study to Evaluate the Immune Response to Anti-HER2 Therapies

    Jacksonville, FL

  7. Pragmatic Comparative Clinical Trial to Determine Optimal Initial Therapy for Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN, La Crosse, WI

  8. Localized Leiomyosarcoma Biomarker Protocol

    Rochester, MN

  9. A Study to Evaluate Circulating Tumor DNA (ctDNA) and Immunophenotyping as Potential Biomarkers in Patients Undergoing Regional Nodal Irradiation for Breast Cancer

    Rochester, MN

  10. Innovative CAR-TIL immunotherapy against melanoma

    Jacksonville, FL

.

Mayo Clinic Footer